Literature DB >> 11204741

Characterization of the murine epidermal 12/15-lipoxygenase.

M McDonnell1, W Davis, H Li, C D Funk.   

Abstract

The murine lipoxygenase (LO) family consists of at least seven members classified according to the HETE (hydroxyeicosatetraenoic acid) metabolite generated during arachidonic acid metabolism and the site of tissue expression. At present there are four 12-lipoxygenases that are functionally distinct, vary in cell and tissue distribution, catalytic activity and each are products of separate, linked genes. They are "platelet-type" 12-LO (P-12LO), "leukocyte-type" 12-LO (L-12LO), "epidermal-type" 12-LO (e-12LO) and the most recently discovered 12(R)-LO. In this report we characterize e-12LO, which was overexpressed in the baculovirus/insect cell expression system. The enzyme functions as a dual specificity 12/15-lipoxygenase with a 12-HETE/15-HETE product ratio of approximately 6:1 with arachidonic acid as substrate. Several other polyunsaturated fatty acids served as substrates for e-12LO such as gamma-linolenic, dihomo-gamma-linolenic and eicosapentaenoic acids. A green fluorescent protein/e-12LO fusion protein was localized to the cytosol of transfected HEK 293 cells. The e-12LO gene was expressed in mouse oocytes and early embryos. Western blot analysis revealed high level expression in postnatal day 3 mouse epidermal lysates. Together these data suggest that e-12LO plays a role in normal epidermal function and as yet an undiscovered role in early development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11204741     DOI: 10.1016/s0090-6980(00)00100-3

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  8 in total

Review 1.  Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery.

Authors:  Ganesh V Halade; Laurence M Black; Mahendra Kumar Verma
Journal:  Biotechnol Adv       Date:  2018-02-28       Impact factor: 14.227

2.  Systematic analysis of rat 12/15-lipoxygenase enzymes reveals critical role for spinal eLOX3 hepoxilin synthase activity in inflammatory hyperalgesia.

Authors:  Ann M Gregus; Darren S Dumlao; Spencer C Wei; Paul C Norris; Laura C Catella; Flore G Meyerstein; Matthew W Buczynski; Joanne J Steinauer; Bethany L Fitzsimmons; Tony L Yaksh; Edward A Dennis
Journal:  FASEB J       Date:  2013-02-04       Impact factor: 5.191

Review 3.  Significance of lipid mediators in corneal injury and repair.

Authors:  Sachidananda Kenchegowda; Haydee E P Bazan
Journal:  J Lipid Res       Date:  2009-11-03       Impact factor: 5.922

4.  Lipoxygenase pathways in Homo neanderthalensis: functional comparison with Homo sapiens isoforms.

Authors:  Pavlos Chaitidis; Susan Adel; Monika Anton; Dagmar Heydeck; Hartmut Kuhn; Thomas Horn
Journal:  J Lipid Res       Date:  2013-03-10       Impact factor: 5.922

5.  12/15-Lipoxygenase deficiency reduces densities of mesenchymal stem cells in the dermis of wounded and unwounded skin.

Authors:  S Hong; B V Alapure; Y Lu; H Tian; Q Wang
Journal:  Br J Dermatol       Date:  2014-07-17       Impact factor: 9.302

6.  Quantitative determination of 12-hydroxyeicosatetraenoic acids by chiral liquid chromatography tandem mass spectrometry in a murine atopic dermatitis model.

Authors:  Seong-Ho Hong; Ji Eun Han; Ji-Seung Ko; Sun Hee Do; Eung Ho Lee; Myung-Haing Cho
Journal:  J Vet Sci       Date:  2015-03-20       Impact factor: 1.672

7.  12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance.

Authors:  Hong-Zhao Xu; Yan-Li Cheng; Wan-Ning Wang; Hao Wu; Yuan-Yuan Zhang; Chong-Sen Zang; Zhong-Gao Xu
Journal:  Int J Mol Sci       Date:  2016-05-06       Impact factor: 5.923

Review 8.  Current knowledge of the implication of lipid mediators in psoriasis.

Authors:  Mélissa Simard; Sophie Morin; Zainab Ridha; Roxane Pouliot
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.